CS
CRMD icon

Credit Suisse’s CorMedix CRMD Stock Holding History

Credit Suisse’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20
Closed – – 4076
2022
Q2 		$0 Sell
20
-752,693
-100% -$2.8M ﹤0.01% 3990
2022
Q1 		$4.13M Sell
752,713
-2,122
-0.3% -$9.72K ﹤0.01% 1598
2021
Q4 		$3.43M Buy
754,835
+4,396
+0.6% +$21.8K ﹤0.01% 2332
2021
Q3 		$3.49M Sell
750,439
-94
-0% -$547 ﹤0.01% 2350
2021
Q2 		$5.15M Sell
750,533
-2,950
-0.4% -$23.5K ﹤0.01% 2058
2021
Q1 		$7.53M Buy
+753,483
New +$7.93M ﹤0.01% 1776
2016
Q3 		– Sell
-18,586
Closed -$185K – 4103
2016
Q2 		$185K Buy
+18,586
New +$283K ﹤0.01% 3896
2015
Q3 		– Sell
-2,775
Closed -$54K – 4296
2015
Q2 		$54K Sell
2,775
-3,343
-55% -$115K ﹤0.01% 4456
2015
Q1 		$301K Buy
+6,118
New +$145K ﹤0.01% 3859

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
SC
Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Credit Suisse's CRMD Position: Q3 2022 in Review

Credit Suisse sold out of CorMedix (CRMD) in Q3 2022, closing a stake of 20 shares.

Credit Suisse first reported a position in CRMD in Q1 2015 and held it in 9 quarters. The position peaked at $7.53M in Q1 2021. 73 funds tracked by Wall St. Rank hold CRMD as of Q3 2022.

  • Credit Suisse reported no remaining CorMedix position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 20 CorMedix shares in Q3 2022.
  • Credit Suisse first reported a position in CorMedix in Q1 2015 and held it in 9 quarters.
  • Credit Suisse's CorMedix position peaked at $7.53M in Q1 2021.
  • 73 funds tracked by Wall St. Rank held CorMedix as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.